Organovo, Inc.: Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ...
Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...
Organovo Holdings Appoints Norman Staskey as New CFO
Organovo Holdings ( (ONVO) ) has issued an announcement.